NL-OMON44817已完成2 期
MagSNOLL: Magnetic Sentinel Node and Occult Lesion Localisation: A feasibility study using magnetic nano particles for sentinel node biopsy and localization of occult breast cancers. - MagSNOLL Multicentre study
niversiteit Twente0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1) Patients (male or female) with histologically proven breast cancer visible on ultrasound and suitable for SLNB.
- •2) Patients available for follow-up for at least 12 months
排除标准
- •1) Intolerance / hypersensitivity to iron or dextran compounds or Sienna+.
- •2) Patients who cannot/ do not receive radioisotope for SLNB.
- •3) Patients with an iron overload disease
- •4) Patients with pacemakers or other implantable devices in the chest-wall.;Exclusion criteria MRI subprotocol:
- •1) Metallic splinters in the eye
- •2) Ferromagnetic haemostatic clips in the central nervous system.
- •3) Claustrophobia.
研究者
相似试验
尚未招募
不适用
MagSNOLL multicenter StudyPatients (male or female) with histologically proven non-palpable breast cancer visible on ultrasound and suitable for SLNBNL-OMON26455Guy's and St Thomas Hospitals, UK60
已完成
不适用
Magnetic Sentinel Node and Occult Lesion Localisation (MagSNOLL)CancerISRCTN68689512King's College London (UK)50
已完成
2 期
Sentinel Node Biopsy using Magnetic Nanoparticles: A prospective multicentre phase II non-randomised clinical trial to compare sentinel node biopsy using magnetic nanoparticles vs. standard techniqueNL-OMON40081King's College London75
已完成
不适用
SentiMAG multicentre trialMalignant neoplasm of breastBreast CancerCancerISRCTN35827879King's College London (UK)160
已完成
不适用
The MOLL trial - Magnetic lesion localisation for breast cancerSpecialty: Cancer, Primary sub-specialty: Breast CancerUKCRC code/ Disease: Cancer/ Malignant neoplasm of breastBreast CancerCancerISRCTN74635349Guy's and St Thomas' NHS Foundation Trust20